Early-stage
UK - LSP and SR One lead £16m investment in Syntaxin
Life Science Partners (LSP) and SR One, GlaxoSmithKline's independent corporate healthcare fund, have led an investment of ТЃ16m in biopharmaceutical company Syntaxin Ltd in a series-B funding round.
ITALY - Finlombarda invests EUR 1m in biotech business
Finlombarda Gestioni has invested EUR 1m in TOP srl, a spinout of the University of Milan.
UK - 3i leads $26m funding round in CamSemi
3i has led a $26m investment in fabless semiconductor company CamSemi.
UK - London Seed Capital leads £600,000 investment in cancer innovators
London Seed Capital has led a ТЃ600,000 round of funding into Michelson Diagnostics Ltd, a manufacturer and developer of optical medical imaging equipment specifically designed for use during cancer operations.
UK - Catapult leads £1.2m investment in Synchro
Catapult Venture Managers Ltd has led a ТЃ1.2m investment into software developers Synchro Ltd.
UK - The Capital Fund backs Biocontrol with £500,000
The Capital Fund has invested ТЃ250,000 as part of a ТЃ500,000 funding round in Biocontrol. Biocontrol's research focuses on developing the clinical use of bacteriophages, that is naturally occuring viruses, which attack and destroy harmful bacteria....
UK - Oxford Capital Partners leads £1.58m investment in Green Biologics
Oxford Capital Partners has led a ТЃ1.58m funding round in Green Biologics, a specialist developer of 'next generation' biofuels.
UK - YFM invests in Dynmark
In a second round of funding, the South West Ventures Fund, managed by the YFM Group, has made an undisclosed investment in Dynmark International Ltd, a mobile phone messaging applications developer.